Co-infections during COVID-19 may worsen patients' outcomes. This study reports the
results of a screening assessing the presence of co-infections among patients hospitalized …

Bacterial co-infection in COVID-19 patients significantly contributes to the worsening of the
prognosis based on morbidity and mortality. Information on the co-infection profile in such …

Accurate characterization of respiratory bacterial co-infection is critical for guiding empirical
antibiotic treatment for hospitalised patients with coronavirus disease 2019 (COVID-19). We …

Background We defined the frequency of respiratory community-acquired bacterial co-
infection in patients with COVID-19, ie patients with a positive SARS-CoV-2 PCR or a COVID …

Background. Co-infection rates increase in patients admitted to the Intensive Care Units. The
aim of this study was to examine the Healthcare Associated Infections in critically ill adult …

Background We performed a nationwide population-based retrospective study to describe
the epidemiology of bacterial co-infections in coronavirus disease 2019 (COVID-19) …

Purpose To investigate antimicrobial use and primary and nosocomial infections in
hospitalized COVID-19 patients to provide data for guidance of antimicrobial therapy …

The prevalence of patients hospitalized in ICUs with COVID-19 and co-infected by
pathogenic bacteria is relevant in this study, considering the integrality of treatment. This …

Background: COVID-19 pneumonia with an unusual outbreak is considered a new, global
public health threat. Microbiological characterization of co-infections in patients with COVID …

Objectives To describe the prevalence and nature of bacterial co-infections in COVID-19
patients within 48 hours of hospital admission and assess the appropriateness of empirical …